Copy and paste this code to insert a reference to this article in your
blog or online community profile:
Risk Factors Associated with lower extremity amputation in diabetic patients with neuropathic ulcerations of the foot treated with human recombinant Epidermal Growth factor (Heberprot P).
Clin Res Foot Ankle 2022, 10:6. 10:6, (2022)
https://doi.org/10.4172/2329-910X.1000352
Highlight
Will Display Like this:
Risk Factors Associated with lower extremity amputation in diabetic patients with neuropathic ulcerations of the foot treated with human recombinant Epidermal Growth factor (Heberprot P).
Clin Res Foot Ankle 2022, 10:6. 10:6, (2022)
https://doi.org/10.4172/2329-910X.1000352
Powered by
OMICS International